Skip to main navigation Skip to search Skip to main content

Progressive multifocal leucoencephalopathy after autologous bone marrow transplantation: A treatment option

Research output: Contribution to journal › Article › peer-review

Abstract

A patient with multiple myeloma was treated with high-dose chemotherapy followed by two autologous bone marrow transplantations (ABMTs). Nine months after the second ABMT the patient complained of severe left hemiparesis, paraesthesias, left homonymous visual field defects and gait ataxia. She was diagnosed with progressive multifocal leucoencephalopathy (PML) confirmed by detection of JC virus (JCV) DNA and prescribed cidofovir every other week and mirtazapine daily. Her symptoms and signs remained stable and after 6 months the JCV DNA was undetectable in the cerebrospinal fluid. Repeated MRI scans demonstrated the stabilisation of demyelinating lesion volume; after more than 2 years of follow-up the patient's neurological examination does not show significant variations. Combination of cidofovir and mirtazapine may be helpful in the treatment of PML in HIV-negative patients.
Original languageEnglish
JournalBMJ CASE REPORT
DOIs
Publication statusPublished - 1 Jan 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Progressive multifocal leucoencephalopathy after autologous bone marrow transplantation: A treatment option'. Together they form a unique fingerprint.

Cite this